MX9604004A - Aerosol drug formulations containing vitamin e. - Google Patents

Aerosol drug formulations containing vitamin e.

Info

Publication number
MX9604004A
MX9604004A MX9604004A MX9604004A MX9604004A MX 9604004 A MX9604004 A MX 9604004A MX 9604004 A MX9604004 A MX 9604004A MX 9604004 A MX9604004 A MX 9604004A MX 9604004 A MX9604004 A MX 9604004A
Authority
MX
Mexico
Prior art keywords
formulations containing
drug formulations
containing vitamin
aerosol drug
medicament
Prior art date
Application number
MX9604004A
Other languages
Spanish (es)
Other versions
MXPA96004004A (en
Inventor
Mou-Ying Fu Lu
Pramod K Gupta
Arwete L Adjei
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX9604004A publication Critical patent/MX9604004A/en
Publication of MXPA96004004A publication Critical patent/MXPA96004004A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions for aerosol delivery comprising (a) a medicament, (b) a non-chlorofluorocarbon propellant, and (c) tocopherol or a pharmaceutically acceptable derivative thereof, as well as a method for preparing such compositions in which unwanted aggregation of the medicament is prevented without the use of surfactants or cosolvents.
MXPA/A/1996/004004A 1994-03-14 1996-09-10 Formulations of aerosol drugs containing vitamin MXPA96004004A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21247294A 1994-03-14 1994-03-14
US212472 1994-03-14
PCT/US1995/002764 WO1995024892A1 (en) 1994-03-14 1995-03-02 Aerosol drug formulations containing vitamin e

Publications (2)

Publication Number Publication Date
MX9604004A true MX9604004A (en) 1997-12-31
MXPA96004004A MXPA96004004A (en) 1998-09-18

Family

ID=

Also Published As

Publication number Publication date
AU709783B2 (en) 1999-09-09
EP0804157A1 (en) 1997-11-05
WO1995024892A1 (en) 1995-09-21
KR970701535A (en) 1997-04-12
AU1980495A (en) 1995-10-03
IL112897A0 (en) 1995-06-29
JPH09510445A (en) 1997-10-21
CA2183557A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
WO1996040089A3 (en) Aerosol drug formulations containing vegetable oils
DK0731688T3 (en) Aerosol drug formulations for use with CFC-free propellants
MY118371A (en) Tetrahydrolipstatin containing compositions
YU59899A (en) Medicinal aerosol products
AU3038197A (en) Aerosol formulations
EP1277467A3 (en) Non-chlorofluorocarbon aerosol formulations
GR3019374T3 (en) Non-chlorofluorocarbon aerosol formulations
AU4260496A (en) Propellant mixture for aerosol formulation
JO2381B1 (en) Formulations containing an antich holinergic drug for the treatment of chronic obstructive pulmonary disease
CA2125665A1 (en) Medicaments
CA2189328A1 (en) Tocopherol compositions for delivery of biologically active agents
CA2362539A1 (en) Fluorocarbon aerosol medicaments
HK130397A (en) Aerosol formulation comprising beclomethasone 17,21 dipropionate
CA2058428A1 (en) Analgesic formulations
MY130946A (en) Medicinal inhalation aerosol formulations containing budesonide
WO1999051271A3 (en) Compositions comprising glycol derivatives and alcohols
AU2084801A (en) Antiviral medication
NO980858D0 (en) Pharmaceutical preparations and devices for administration thereof
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
MX9604004A (en) Aerosol drug formulations containing vitamin e.
HUP0301415A2 (en) Method for formulating healthcare products with enhanced stability
AU6326094A (en) New medicament aerosol formulation based on fusafungine, a process for its preparation and pharmaceutical compositions containing it
EP1523976A3 (en) Pharmaceutical formulations of salmeterol
AU2003215588A1 (en) Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
MX9707238A (en) Butixocort aerosol formulations.